Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1997 3
1998 1
2003 1
2004 2
2005 2
2006 6
2007 1
2008 11
2009 7
2010 3
2011 3
2012 1
2014 1
2016 1
2017 2
2021 2
2023 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
'Tis but a scratch: a critical review of the Women's Health Initiative evidence associating menopausal hormone therapy with the risk of breast cancer.
Bluming AZ, Hodis HN, Langer RD. Bluming AZ, et al. Among authors: langer rd. Menopause. 2023 Dec 1;30(12):1241-1245. doi: 10.1097/GME.0000000000002267. Epub 2023 Oct 18. Menopause. 2023. PMID: 37847875 Free PMC article. Review.
Use of menopausal hormone therapy (HT) fell precipitously after 2002, largely as a result of the Women's Health Initiative's report claiming that the combination of conjugated equine estrogen (CEE) and medroxyprogesterone acetate increased breast cancer risk and did not im …
Use of menopausal hormone therapy (HT) fell precipitously after 2002, largely as a result of the Women's Health Initiative's report claiming …
The bioelectrical impedance analysis (BIA) international database: aims, scope, and call for data.
Silva AM, Campa F, Stagi S, Gobbo LA, Buffa R, Toselli S, Silva DAS, Gonçalves EM, Langer RD, Guerra-Júnior G, Machado DRL, Kondo E, Sagayama H, Omi N, Yamada Y, Yoshida T, Fukuda W, Gonzalez MC, Orlandi SP, Koury JC, Moro T, Paoli A, Kruger S, Schutte AE, Andreolli A, Earthman CP, Fuchs-Tarlovsky V, Irurtia A, Castizo-Olier J, Mascherini G, Petri C, Busert LK, Cortina-Borja M, Bailey J, Tausanovitch Z, Lelijveld N, Ghazzawi HA, Amawi AT, Tinsley G, Kangas ST, Salpéteur C, Vázquez-Vázquez A, Fewtrell M, Ceolin C, Sergi G, Ward LC, Heitmann BL, da Costa RF, Vicente-Rodriguez G, Cremasco MM, Moroni A, Shepherd J, Moon J, Knaan T, Müller MJ, Braun W, García-Almeida JM, Palmeira AL, Santos I, Larsen SC, Zhang X, Speakman JR, Plank LD, Swinburn BA, Ssensamba JT, Shiose K, Cyrino ES, Bosy-Westphal A, Heymsfield SB, Lukaski H, Sardinha LB, Wells JC, Marini E. Silva AM, et al. Among authors: langer rd. Eur J Clin Nutr. 2023 Dec;77(12):1143-1150. doi: 10.1038/s41430-023-01310-x. Epub 2023 Aug 2. Eur J Clin Nutr. 2023. PMID: 37532867
Progesterone from ovulatory menstrual cycles is an important cause of breast cancer.
Coelingh Bennink HJT, Schultz IJ, Schmidt M, Jordan VC, Briggs P, Egberts JFM, Gemzell-Danielsson K, Kiesel L, Kluivers K, Krijgh J, Simoncini T, Stanczyk FZ, Langer RD. Coelingh Bennink HJT, et al. Among authors: langer rd. Breast Cancer Res. 2023 May 30;25(1):60. doi: 10.1186/s13058-023-01661-0. Breast Cancer Res. 2023. PMID: 37254150 Free PMC article. Review.
Many factors, including reproductive hormones, have been linked to a woman's risk of developing breast cancer (BC). We reviewed the literature regarding the relationship between ovulatory menstrual cycles (MCs) and BC risk. ...
Many factors, including reproductive hormones, have been linked to a woman's risk of developing breast cancer (BC). We reviewed the l …
The role of medications in successful aging.
Langer RD. Langer RD. Climacteric. 2021 Oct;24(5):505-512. doi: 10.1080/13697137.2021.1911991. Epub 2021 May 12. Climacteric. 2021. PMID: 33977831 Review.
Considering disease-adjusted life years, other leading causes are chronic obstructive pulmonary disease, diabetes mellitus, dementias, hearing loss, cancers of the breast, lung and bowel, osteoporosis, fractures and falls, depression, osteoarthritis, refractive errors of t …
Considering disease-adjusted life years, other leading causes are chronic obstructive pulmonary disease, diabetes mellitus, dementias, heari …
Hormone replacement therapy - where are we now?
Langer RD, Hodis HN, Lobo RA, Allison MA. Langer RD, et al. Climacteric. 2021 Feb;24(1):3-10. doi: 10.1080/13697137.2020.1851183. Epub 2021 Jan 6. Climacteric. 2021. PMID: 33403881 Review.
Hormone replacement therapy (HRT) was the standard of care for menopause management until 2002, when perceptions changed following release of the initial results from the Women's Health Initiative (WHI) trial. Fears of breast cancer and heart attacks engendered by that rep …
Hormone replacement therapy (HRT) was the standard of care for menopause management until 2002, when perceptions changed following release o …
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.
Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH. Langer RD, et al. Climacteric. 2017 Oct;20(5):402-413. doi: 10.1080/13697137.2017.1362156. Epub 2017 Aug 14. Climacteric. 2017. PMID: 28805475
Furthermore, major elements of the evidence relied upon have been misinterpreted or misstated, particularly in regard to coronary heart disease and breast cancer, for which there is no statistically significant evidence of harm. As currently drafted, the recommendations re …
Furthermore, major elements of the evidence relied upon have been misinterpreted or misstated, particularly in regard to coronary heart dise …
The evidence base for HRT: what can we believe?
Langer RD. Langer RD. Climacteric. 2017 Apr;20(2):91-96. doi: 10.1080/13697137.2017.1280251. Epub 2017 Mar 10. Climacteric. 2017. PMID: 28281363 Review.
HRT use plummeted world-wide, driven by fear of breast cancer and skepticism about cardiovascular benefits. Stunningly, the contrasting findings of the WHI trial of CEE alone reported 2 years later - suggesting prevention of coronary heart disease in women who began HRT at …
HRT use plummeted world-wide, driven by fear of breast cancer and skepticism about cardiovascular benefits. Stunningly, the contrasti …
Hypnotics' association with mortality or cancer: a matched cohort study.
Kripke DF, Langer RD, Kline LE. Kripke DF, et al. Among authors: langer rd. BMJ Open. 2012 Feb 27;2(1):e000850. doi: 10.1136/bmjopen-2012-000850. Print 2012. BMJ Open. 2012. PMID: 22371848 Free PMC article.
MAIN OUTCOME MEASURES: Data were adjusted for age, gender, smoking, body mass index, ethnicity, marital status, alcohol use and prior cancer. Hazard ratios (HRs) for death were computed from Cox proportional hazards models controlled for risk factors and using up to 116 st …
MAIN OUTCOME MEASURES: Data were adjusted for age, gender, smoking, body mass index, ethnicity, marital status, alcohol use and prior can …
50 results